A randomised public-health trial on automation-assisted screening for cervical cancer in Finland: Performance with 470,000 invitations

International Journal of Cancer

Volumn 115, Issue 2, 2005, Pages 307-311

  Nieminen, Pekka ^a   Kotaniemi, Laura ^b   Hakama, Matti ^c   Tarkkanen, Jussi ^a   Martikainen, Jorma ^d   Toivonen, Terttu ^e   Ikkala, Jorma ^f   Luostarinen, Tapio ^b   Anttila, Ahti ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d Pathol Lab of Finnish Cancer Soc   (Finland)

^e Pathol Lab of Finnish Cancer Soc   (Finland)

^f Papa Center   (Finland)

Author keywords

Cervical cancer; Cytology; Epidemiology; Public health; Randomised trial; Screening

Indexed keywords

ADULT; ARTICLE; AUTOMATION; CANCER INCIDENCE; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FINLAND; FOLLOW UP; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; PAPANICOLAOU TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA;

ADULT; AUTOMATION; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FINLAND; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; PUBLIC HEALTH; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 17844384853     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20902     Document Type: Article

References (22)

1. Fidler HK, Boyes DA, Worth AJ. Cervical cancer detection in British Columbia. J Obstet Gynecol Br Commonw 1968;75:392-404.
2. Hakama M, Räsänen-Virtanen U. Effect of a mass screening program on the risk of cervical cancer. Am J Epidemiol 1976;103:512-7.
3. Hakama M. Trends in the incidence of cervical cancer in the Nordic countries. In: Magnus K, ed. Trends in cancer incidence. New York: Hemisphere: 1982.279-92.
4. Läärä E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987;1:1247-9.
5. Lynge E, Madsen M, Engholm G. Effect of organised screening on incidence and mortality of cervical cancer in Denmark. Cancer Res 1989;49:2157-60.
6. Anttila A, Pukkala E, Soderman B, Kallio M, Nieminen P, Hakama M. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: a recent increase in the incidence. Int J Cancer 1999;83:59-63.
7. Sankila R, Démaret E, Hakama M, Lynge E, Schouten LJ, Parkin DM, eds. for the European Network of Cancer Registries. Evaluation and monitoring of screening programmes. Brussels: European Commission, Europe Against Cancer Programme, 2000.
8. Finnish Cancer Registry. Cancer incidence in Finland 2000 and 2001. Helsinki: Cancer Society of Finland, no. 65, 2003.
9. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer incidence in five continents, vol. VIII. IARC Scientific Publications, no. 155. Lyon: IARC and International Association of Cancer Registries, 2002.
10. Kok MR, Boon ME. Consequences of neural network technology for cervical screening: increase in diagnostic consistency and positive scores. Cancer 1996;78:112-7.
11. Nieminen P, Hakama M, Viikki M, Tarkkanen J, Anttila A. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year. Int S Cancer 2003;103:422-6.
12. Anttila A, Nieminen P. Cervical cancer screening programme in Finland. Eur J Cancer 2000;36:2209-14.
13. Breslow NE, Day NE. The design and analysis of cohort studies. IARC Scientific Publications, no 82. Lyon: IARC, 1987.
14. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med 1985;4:213-26.
15. Irwig L, Macaskill P, Farnsworth A, Wright RG, McCool J, Barratt A, Simpson JM. A randomized crossover trial of PAPNET for primary cervical screening. J Clin Epidemiol 2003;57:75-81.
16. Nieminen P, Vuorma S, Viikki M, Hakama M, Anttila A. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. BJOG 2004;111:842-8.
17. Doornewaard H, van den Schouw YT, van der Graaf Y, Bos AB, Habbema JD, van den Tweel JG. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study. Mod Pathol 1999;12:995-1000.
18. Duggan MA. Papnet-assisted, primary screening of cervico-vaginal smears. Eur J Gynaecol Oncol 2000;44:151-7.
19. Cucizk J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997;16: 1017-29.
20. Viikki M, Pukkala E, Hakama M. Risk of cervical cancer after a negative pap smear. J Med Screen 1999;6:103-7.
21. Moss SM, Gray A, Legood R, Henstock E. Evaluation of HPV/LBC. Cervical screening pilot studies. First report to the Department of Health on evaluation of LBC: 1-96. [http://www.cancerscreening. nhs.uk/cervical/lbc-pilot-evaluation. pdf]. 2003.
22. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362: 1871-6.